11-116791691-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001371904.1(APOA5):​c.56C>G​(p.Ser19Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0624 in 1,607,778 control chromosomes in the GnomAD database, including 3,555 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S19L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.065 ( 352 hom., cov: 34)
Exomes 𝑓: 0.062 ( 3203 hom. )

Consequence

APOA5
NM_001371904.1 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 1.58

Publications

366 publications found
Variant links:
Genes affected
APOA5 (HGNC:17288): (apolipoprotein A5) The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009]
APOA5 Gene-Disease associations (from GenCC):
  • hypertriglyceridemia 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hyperlipoproteinemia type V
    Inheritance: AD, SD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018840134).
BP6
Variant 11-116791691-G-C is Benign according to our data. Variant chr11-116791691-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 4403.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371904.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOA5
NM_001371904.1
MANE Select
c.56C>Gp.Ser19Trp
missense
Exon 2 of 3NP_001358833.1Q6Q788
APOA5
NM_001166598.2
c.56C>Gp.Ser19Trp
missense
Exon 3 of 4NP_001160070.1A0A0B4RUS7
APOA5
NM_052968.5
c.56C>Gp.Ser19Trp
missense
Exon 3 of 4NP_443200.2Q6Q788

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOA5
ENST00000227665.9
TSL:1 MANE Select
c.56C>Gp.Ser19Trp
missense
Exon 2 of 3ENSP00000227665.4Q6Q788
APOA5
ENST00000433069.2
TSL:1
c.56C>Gp.Ser19Trp
missense
Exon 3 of 4ENSP00000399701.2Q6Q788
APOA5
ENST00000673688.1
c.56C>Gp.Ser19Trp
missense
Exon 2 of 3ENSP00000501141.1A0A669KB69

Frequencies

GnomAD3 genomes
AF:
0.0649
AC:
9872
AN:
152200
Hom.:
349
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0619
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.0657
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0405
Gnomad FIN
AF:
0.0551
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0628
Gnomad OTH
AF:
0.0779
GnomAD2 exomes
AF:
0.0684
AC:
16228
AN:
237114
AF XY:
0.0645
show subpopulations
Gnomad AFR exome
AF:
0.0635
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.0681
Gnomad EAS exome
AF:
0.000286
Gnomad FIN exome
AF:
0.0608
Gnomad NFE exome
AF:
0.0640
Gnomad OTH exome
AF:
0.0701
GnomAD4 exome
AF:
0.0621
AC:
90359
AN:
1455460
Hom.:
3203
Cov.:
33
AF XY:
0.0610
AC XY:
44118
AN XY:
723514
show subpopulations
African (AFR)
AF:
0.0645
AC:
2148
AN:
33286
American (AMR)
AF:
0.147
AC:
6413
AN:
43700
Ashkenazi Jewish (ASJ)
AF:
0.0653
AC:
1697
AN:
25982
East Asian (EAS)
AF:
0.000559
AC:
22
AN:
39364
South Asian (SAS)
AF:
0.0387
AC:
3297
AN:
85286
European-Finnish (FIN)
AF:
0.0626
AC:
3319
AN:
52982
Middle Eastern (MID)
AF:
0.0542
AC:
312
AN:
5760
European-Non Finnish (NFE)
AF:
0.0627
AC:
69507
AN:
1108956
Other (OTH)
AF:
0.0606
AC:
3644
AN:
60144
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
5272
10543
15815
21086
26358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2602
5204
7806
10408
13010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0649
AC:
9890
AN:
152318
Hom.:
352
Cov.:
34
AF XY:
0.0642
AC XY:
4778
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0619
AC:
2574
AN:
41574
American (AMR)
AF:
0.114
AC:
1737
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0657
AC:
228
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0408
AC:
197
AN:
4832
European-Finnish (FIN)
AF:
0.0551
AC:
585
AN:
10616
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0628
AC:
4275
AN:
68026
Other (OTH)
AF:
0.0776
AC:
164
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
494
987
1481
1974
2468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0542
Hom.:
191
Bravo
AF:
0.0704
TwinsUK
AF:
0.0620
AC:
230
ALSPAC
AF:
0.0643
AC:
248
ESP6500AA
AF:
0.0611
AC:
269
ESP6500EA
AF:
0.0649
AC:
558
ExAC
AF:
0.0620
AC:
7527
Asia WGS
AF:
0.0300
AC:
104
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial type 5 hyperlipoproteinemia;C5444012:Hypertriglyceridemia 1 (1)
-
-
-
Hypertriglyceridemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.48
T
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
2.0
M
PhyloP100
1.6
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.22
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.99
D
Vest4
0.43
MPC
1.5
ClinPred
0.017
T
GERP RS
5.4
PromoterAI
-0.0094
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.098
gMVP
0.42
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3135506; hg19: chr11-116662407; COSMIC: COSV57062904; COSMIC: COSV57062904; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.